Search - tctmd.com

Displaying 361 - 380 of 782

Sort: Relevancy | Date

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Industry News

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

September 03, 2014

News Daily News

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Yael L. Maxwell

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

Todd Neale

August 31, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

Advertisement

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Experts Debate Future of Renal Denervation Therapy

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content